Status:
COMPLETED
Pilot-trial Testing Remote Sleep Apnea Evaluation in Patients with Atrial Fibrillation
Lead Sponsor:
Herlev and Gentofte Hospital
Conditions:
Atrial Fibrillation
Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an investigator-initiated virtual (or decentralized) trial that includes a postal parcel (mail-in) containing sensors for SA diagnosis (NightOwl™) and physical activity (SENS Motion), in addit...
Detailed Description
Objectives The main aim of the pilot trial is in a completely decentralized/virtual setting to evaluate whether SA home-evaluation, physical tracking by a home-monitoring device and heart rhythm monit...
Eligibility Criteria
Inclusion
- Age\>18 years
- Established paroxysmal or persistent AF diagnosis
- Owning a compatible smartphone (or accepting a smart phone provided by the investigators)
- Understanding of potential SA treatment possibilities including CPAP treatment
Exclusion
- Previous investigation for sleep-disturbed breathing
- Advanced heart failure (left ventricular dysfunction and NYHA III/IV)
- Occupational driver licenses
- Pregnancy
- Doxazosin or Terazosin (alpha-adrenergic antagonists)
- Peripheral arterial disease with daily intermittent claudication
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06188247
Start Date
December 1 2023
End Date
August 1 2024
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev and Gentofte Hospital
Gentofte Municipality, Denmark